Independent auditor tenure and accounting policy changes disclosed by AMGEN INC (AMGN)
Independent auditor tenure and accounting policy changes disclosed by AMGEN INC (AMGN)
Official regulatory documentation registered with the U.S. Securities and Exchange Commission (SEC) identifies AMGEN INC (trading under ticker AMGN) as a publicly reporting corporate entity operating under Standard Industrial Classification (SIC) code for Biological Products, (No Diagnostic Substances). As a registered public issuer, AMGEN INC is mandated under the Securities Exchange Act of 1934 to provide comprehensive periodic disclosures, including annual Form 10-K filings, quarterly Form 10-Q financial updates, and current material event notifications on Form 8-K. Institutional risk managers and fundamental quantitative analysts evaluate AMGEN INC's regulatory transparency, capital structure integrity, and corporate governance standards within the BIOTECH_FDA authority cluster to benchmark sector resilience and compliance discipline.
Verified Quantitative Data
| Metric | Value |
|---|---|
| Org | company |
| Sic | Biological Products, (No Diagnostic Substances) |
Full trading intelligence, federal contract history and congressional flow for AMGN.
Primary Source Record
This fact is compiled from public federal disclosure records. Explore the underlying dataset on the Federal Contract Explorer and the Capitol Trades leaderboard.
Data intelligence from public filings — not investment advice.